BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18271520)

  • 1. Discovery of kinase inhibitors by high-throughput docking and scoring based on a transferable linear interaction energy model.
    Kolb P; Huang D; Dey F; Caflisch A
    J Med Chem; 2008 Mar; 51(5):1179-88. PubMed ID: 18271520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient evaluation of binding free energy using continuum electrostatics solvation.
    Huang D; Caflisch A
    J Med Chem; 2004 Nov; 47(23):5791-7. PubMed ID: 15509178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based tailoring of compound libraries for high-throughput screening: discovery of novel EphB4 kinase inhibitors.
    Kolb P; Kipouros CB; Huang D; Caflisch A
    Proteins; 2008 Oct; 73(1):11-8. PubMed ID: 18384152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General model for estimation of the inhibition of protein kinases using Monte Carlo simulations.
    Tominaga Y; Jorgensen WL
    J Med Chem; 2004 May; 47(10):2534-49. PubMed ID: 15115396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homology models of the mutated EGFR and their response towards quinazoline analogues.
    Kotra S; Madala KK; Jamil K
    J Mol Graph Model; 2008 Oct; 27(3):244-54. PubMed ID: 18585943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved lead-finding for kinase targets using high-throughput docking.
    McInnes C
    Curr Opin Drug Discov Devel; 2006 May; 9(3):339-47. PubMed ID: 16729730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative contributions of desolvation, inter- and intramolecular interactions to binding affinity in protein kinase systems.
    Sims PA; Wong CF; Vuga D; McCammon JA; Sefton BM
    J Comput Chem; 2005 May; 26(7):668-81. PubMed ID: 15754303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining docking, molecular dynamics and the linear interaction energy method to predict binding modes and affinities for non-nucleoside inhibitors to HIV-1 reverse transcriptase.
    Carlsson J; Boukharta L; Aqvist J
    J Med Chem; 2008 May; 51(9):2648-56. PubMed ID: 18410085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postprocessing of protein-ligand docking poses using linear response MM-PB/SA: application to Wee1 kinase inhibitors.
    Wichapong K; Lawson M; Pianwanit S; Kokpol S; Sippl W
    J Chem Inf Model; 2010 Sep; 50(9):1574-88. PubMed ID: 20712342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based optimization of potent and selective inhibitors of the tyrosine kinase erythropoietin producing human hepatocellular carcinoma receptor B4 (EphB4).
    Lafleur K; Huang D; Zhou T; Caflisch A; Nevado C
    J Med Chem; 2009 Oct; 52(20):6433-46. PubMed ID: 19788238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QSAR models for predicting the similarity in binding profiles for pairs of protein kinases and the variation of models between experimental data sets.
    Sheridan RP; Nam K; Maiorov VN; McMasters DR; Cornell WD
    J Chem Inf Model; 2009 Aug; 49(8):1974-85. PubMed ID: 19639957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linear interaction energy models for beta-secretase (BACE) inhibitors: Role of van der Waals, electrostatic, and continuum-solvation terms.
    Tounge BA; Rajamani R; Baxter EW; Reitz AB; Reynolds CH
    J Mol Graph Model; 2006 May; 24(6):475-84. PubMed ID: 16293430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solvated interaction energy (SIE) for scoring protein-ligand binding affinities. 1. Exploring the parameter space.
    Naïm M; Bhat S; Rankin KN; Dennis S; Chowdhury SF; Siddiqi I; Drabik P; Sulea T; Bayly CI; Jakalian A; Purisima EO
    J Chem Inf Model; 2007; 47(1):122-33. PubMed ID: 17238257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High affinity targets of protein kinase inhibitors have similar residues at the positions energetically important for binding.
    Sheinerman FB; Giraud E; Laoui A
    J Mol Biol; 2005 Oct; 352(5):1134-56. PubMed ID: 16139843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docking, 3D-QSAR studies and in silico ADME prediction on c-Src tyrosine kinase inhibitors.
    Tintori C; Magnani M; Schenone S; Botta M
    Eur J Med Chem; 2009 Mar; 44(3):990-1000. PubMed ID: 18722033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applying linear interaction energy method for binding affinity calculations of podophyllotoxin analogues with tubulin using continuum solvent model and prediction of cytotoxic activity.
    Alam MA; Naik PK
    J Mol Graph Model; 2009; 27(8):930-43. PubMed ID: 19286405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction profiles of protein kinase-inhibitor complexes and their application to virtual screening.
    Chuaqui C; Deng Z; Singh J
    J Med Chem; 2005 Jan; 48(1):121-33. PubMed ID: 15634006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of SAMPL-1 hydration free energies using a continuum electrostatics-dispersion model.
    Sulea T; Wanapun D; Dennis S; Purisima EO
    J Phys Chem B; 2009 Apr; 113(14):4511-20. PubMed ID: 19267492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput virtual screening using quantum mechanical probes: discovery of selective kinase inhibitors.
    Zhou T; Caflisch A
    ChemMedChem; 2010 Jul; 5(7):1007-14. PubMed ID: 20540063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exhaustive docking of molecular fragments with electrostatic solvation.
    Majeux N; Scarsi M; Apostolakis J; Ehrhardt C; Caflisch A
    Proteins; 1999 Oct; 37(1):88-105. PubMed ID: 10451553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.